CSL Ltd

Common Name

CSL

Country

Australia

Sector

Healthcare

Industry

Biotechnology

Employees

29,904

Ticker

CSL

Exchange

Australian Securities Exchange

Website

www.csl.com

Description

CSL Limited is a leading Australian multinational biotechnology company specializing in the research, development, manufacturing, and marketing of lifesaving medicines and vaccines. The company’s port... Show more

Income Statement Balance Sheet

CSL's Financial Statements Preview

Below are the financial statements of CSL, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of USD	2024 as of 2024-06-30	2023 as of 2023-06-30
Current assets	—	—
Cash and cash equivalents	1,657^a	1,548^a
Receivables and contract assets	2,895^a	2,214^a
Inventories	5,964^a	5,466^a
Current tax assets	126^a	31^a
Assets held for sale	126^a	0^a
Total current assets	10,768^a	9,259^a
Non-current assets	—	—
Property, plant and equipment	8,148^a	7,797^a
Right-of-use assets	1,510^a	1,555^a
Intangible assets	16,346^a	16,446^a
Deferred tax assets	911^a	902^a
Retirement benefit assets	18^a	6^a
Other financial assets	163^a	173^a
Other non-current assets	158^a	96^a
Total non-current assets	27,254^a	26,975^a
Total assets	38,022^a	36,234^a
Current liabilities	—	—
Trade and other payables	3,345^a	2,947^a
Interest-bearing liabilities and borrowings	944^a	1,055^a
Current tax liabilities	176^a	296^a
Provisions	475^a	310^a
Liabilities held for sale	10^a	0^a
Total current liabilities	4,950^a	4,608^a
Non-current liabilities	—	—
Interest-bearing liabilities and borrowings	11,239^a	11,172^a
Retirement benefit liabilities	282^a	204^a
Deferred tax liabilities	1,514^a	1,464^a
Provisions	186^a	467^a
Other non-current liabilities	450^a	493^a
Total non-current liabilities	13,671^a	13,800^a
Total liabilities	18,621^a	18,408^a
Net assets	19,401^a	17,826^a
Equity	—	—
Contributed equity	557^a	517^a
Reserves	794^a	648^a
Retained earnings	16,012^a	14,621^a
Equity attributable to shareholders of CSL Limited	17,363^a	15,786^a
Non-controlling interests	2,038^a	2,040^a
Total equity	19,401^a	17,826^a

Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources

pro

Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.

Download granular datasets (CSV/XLS)

Access underlying corporate disclosures (PDF)

Trace all values back to their original sources

Start Your 30-Day Free Trial

Formats Included

Excel

CSV

Json

All data fully traceable to original sources

Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind CSL’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. CSL's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

CSL Ltd

CSL's Financial Statements Preview

Verified Sources Behind CSL’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Ucb SA

BeOne Medicines AG

Revolution Medicines Inc

Royalty Pharma PLC

Moderna Inc

Incyte Corp

Account Restricted